search
Back to results

Auditory Slow Wave Enhancement After Concussion

Primary Purpose

Concussion Post Syndrome

Status
Recruiting
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Auditory Stimulation
Sponsored by
University Children's Hospital, Zurich
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Concussion Post Syndrome focused on measuring sleep, auditory stimulation, post-concussive symptoms, in-home EEG

Eligibility Criteria

6 Years - 18 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Informed Consent as documented by signature
  • Age between 6 and 18 years
  • Good knowledge of German of the patient and at least one legal representative
  • Patients: Presentation to the Emergency of the University Children's Hospital Zurich because of a concussion (diagnosed by medical doctor)

Exclusion Criteria:

  • Preterm birth (< 37 gestational weeks)
  • Diagnosed hearing disorder
  • Psychiatric, syndromal, or neurological pre-existing condition (except for previous concussion)
  • Skin disorder/skin problem in the face/ear area that requires Treatment
  • Usage of neuroactive substances
  • Patients: Concomitant injury that requires intense pain medication or a prolonged hospital stay, or that causes limited use of the dominant Hand
  • Patients: Previous moderate-severe TBI
  • Controls: Injury of the dominant hand, on head, arm, or leg
  • Controls: Previous TBI (of any severity)

Additional inclusion criteria for the optional MRI measurement for both groups:

  • Age at least 8 years
  • Fulfilment of all MRI safety criteria
  • The participant and the legal representative would want to know about incidental findings.
  • Girls: No pregnancy or breast feeding.

Sites / Locations

  • University Children's Hospital ZurichRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Intervention group

Control group

Arm Description

Participants in this group will receive all-night auditory stimulation during sleep over one week using a portable, in-home device (MHSL-SleepBand).

Participants in this group will receive sham-stimulation, i.e. the device will be applied (biosignals will be recorded), but no tones will be played.

Outcomes

Primary Outcome Measures

Cognitive Performance - attention
Assessed by standardized test (normative values).
Cognitive Performance - processing speed
Assessed by standardized test (normative values).
Cognitive Performance - executive function
Assessed by standardized test (normative values).

Secondary Outcome Measures

Subjective recovery
Assessed by standardized symptom questionnaires.
Algorithm performance
The algorithm flags which are produced by the mobile device used for the auditory stimulation (i.e. sleep detection flags, stimulation flags). They are used to investigate the algorithm performance for each subject.
Neurological outcome
Measured using Magnetic Resonance Imaging (standard structural and hemodynamic imaging, DTI, and susceptibility weighting) to investigate the neurological outcome.
Injury characteristics
Only for patients: Injury characteristics collected from the Hospital Information System that might influence baseline and follow-up measures and their change over time.
Other possible moderators of the Intervention
For example age and socio-economic status.
EEG power
Power in frequency bands (delta, theta, alpha, beta, gramma).
Sleep stages
EEG, EOG and EMG used for sleep scoring (sleep stages).
Sleep EEG characteristics
Characteristics of sleep EEG Features (slow waves, spindles).
Subjective sleep
Assessed by standardized questionnaire
Actigraphy
Measured by GENEActiv (activity bouts).
Objective and subjective sleep measures
Sleep measured by EEG and actigraphy (objective) as well as questionnaires (subjective)

Full Information

First Posted
February 16, 2021
Last Updated
March 29, 2023
Sponsor
University Children's Hospital, Zurich
Collaborators
ETH Zurich, University of Zurich
search

1. Study Identification

Unique Protocol Identification Number
NCT04770116
Brief Title
Auditory Slow Wave Enhancement After Concussion
Official Title
The Effect of Sleep and Slow Wave Enhancement on Recovery From a Concussion in Children and Adolescents: A Longitudinal, Randomized, Double-Blind, and Sham-Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 31, 2021 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
May 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Children's Hospital, Zurich
Collaborators
ETH Zurich, University of Zurich

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The prevalence of a traumatic brain injury (TBI) in children and adolescents is around 30% with 70-90% being classified as mild (concussion). Because the brain of a child is still developing, a TBI can have devastating effects and possibly creates lifetime challenges. Sleep seems to play an important role in the post-concussion recovery process. Auditory stimulation during sleep has been shown to reliably boost slow waves, a solid marker for the depth of sleep, and can thus be used to deepen sleep. This study aims to investigate the effects of sleep enhancement via auditory stimulation on recovery after a concussion in children and adolescents in their home. Therefore, half of the patients receive one week of auditory stimulation during deep sleep at their home using a mobile device. The other half follows the same study protocol, but no tones are administered (sham). Cognitive tests as well as symptom questionnaires are used to assess the recovery process. It is hypothesized that the patients in the intervention group will recover better than the ones who haven't received the intervention. Additionally, a group of children and adolescents who never sustained a concussion is included as a control.
Detailed Description
In total, 120 participants are planned: 60 patients (30 intervention, 30 sham) and 60 controls (30 intervention, 30 sham). This was estimated from a power analysis and based on previous results. Patients are recruited from the University Children's Hospital Zurich. At first, the participants will complete a baseline assessment of neuropsychological measures (cognitive tests and questionnaires). After completion of the baseline assessment, the participants receive deep sleep enhancement with auditory stimulation for seven nights, but half of them will only receive sham stimulation (device application, but no stimulation). Additionally, they wear an actigraph throughout the whole week. Afterwards, they fill in again some questionnaires (intermediate assessment). One month after study inclusion, the first follow-up will take place where neuropsychological and (optionally) neurological measures will be collected. The second follow-up takes place six months after study inclusion and involves again filling in questionnaires about post-concussive symptoms. The study will be monitored regularly in terms of data validation and source data verification. Adverse events and device deficiencies are carefully documented and reported according to the guidelines of swissmedic and the responsible ethics committee.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Concussion Post Syndrome
Keywords
sleep, auditory stimulation, post-concussive symptoms, in-home EEG

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Study helpers
Allocation
Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention group
Arm Type
Experimental
Arm Description
Participants in this group will receive all-night auditory stimulation during sleep over one week using a portable, in-home device (MHSL-SleepBand).
Arm Title
Control group
Arm Type
Sham Comparator
Arm Description
Participants in this group will receive sham-stimulation, i.e. the device will be applied (biosignals will be recorded), but no tones will be played.
Intervention Type
Device
Intervention Name(s)
Auditory Stimulation
Intervention Description
The device records biosignals and precisely plays tones to enhance sleep slow waves.
Primary Outcome Measure Information:
Title
Cognitive Performance - attention
Description
Assessed by standardized test (normative values).
Time Frame
Measured one month after study inclusion.
Title
Cognitive Performance - processing speed
Description
Assessed by standardized test (normative values).
Time Frame
Measured one month after study inclusion.
Title
Cognitive Performance - executive function
Description
Assessed by standardized test (normative values).
Time Frame
Measured one month after study inclusion.
Secondary Outcome Measure Information:
Title
Subjective recovery
Description
Assessed by standardized symptom questionnaires.
Time Frame
Measured at baseline, one week later (intermediate assessment), one month later (follow-up 1) and six months later (follow-up 2).
Title
Algorithm performance
Description
The algorithm flags which are produced by the mobile device used for the auditory stimulation (i.e. sleep detection flags, stimulation flags). They are used to investigate the algorithm performance for each subject.
Time Frame
Recorded during seven nights of stimulation or sham (intervention week).
Title
Neurological outcome
Description
Measured using Magnetic Resonance Imaging (standard structural and hemodynamic imaging, DTI, and susceptibility weighting) to investigate the neurological outcome.
Time Frame
One month after study inclusion (follow-up 1).
Title
Injury characteristics
Description
Only for patients: Injury characteristics collected from the Hospital Information System that might influence baseline and follow-up measures and their change over time.
Time Frame
baseline, pre-intervention
Title
Other possible moderators of the Intervention
Description
For example age and socio-economic status.
Time Frame
Collected at the baseline assessment.
Title
EEG power
Description
Power in frequency bands (delta, theta, alpha, beta, gramma).
Time Frame
Recorded during the intervention week.
Title
Sleep stages
Description
EEG, EOG and EMG used for sleep scoring (sleep stages).
Time Frame
Recorded during the intervention week.
Title
Sleep EEG characteristics
Description
Characteristics of sleep EEG Features (slow waves, spindles).
Time Frame
Recorded during the intervention week.
Title
Subjective sleep
Description
Assessed by standardized questionnaire
Time Frame
Collected throughout the whole study participation, in total 6 months (baseline, one week later (intermediate assessment), one month later (follow-up 1) and six months later (follow-up 2)).
Title
Actigraphy
Description
Measured by GENEActiv (activity bouts).
Time Frame
Recorded during the intervention week.
Title
Objective and subjective sleep measures
Description
Sleep measured by EEG and actigraphy (objective) as well as questionnaires (subjective)
Time Frame
Recorded at all study visits over a period of six months (baseline assessment, intervention week, follow-up 1 and follow-up 2)..
Other Pre-specified Outcome Measures:
Title
Intervention tolerability
Description
Measured using an intervention evaluation questionnaire (self-designed).
Time Frame
After the intervention week (one week after study inclusion).

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Informed Consent as documented by signature Age between 6 and 18 years Good knowledge of German of the patient and at least one legal representative Patients: Presentation to the Emergency of the University Children's Hospital Zurich because of a concussion (diagnosed by medical doctor) Exclusion Criteria: Preterm birth (< 37 gestational weeks) Diagnosed hearing disorder Psychiatric, syndromal, or neurological pre-existing condition (except for previous concussion) Skin disorder/skin problem in the face/ear area that requires Treatment Usage of neuroactive substances Patients: Concomitant injury that requires intense pain medication or a prolonged hospital stay, or that causes limited use of the dominant Hand Patients: Previous moderate-severe TBI Controls: Injury of the dominant hand, on head, arm, or leg Controls: Previous TBI (of any severity) Additional inclusion criteria for the optional MRI measurement for both groups: Age at least 8 years Fulfilment of all MRI safety criteria The participant and the legal representative would want to know about incidental findings. Girls: No pregnancy or breast feeding.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Reto Huber, Prof.
Phone
0041442668160
Email
reto.huber@kispi.uzh.ch
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Reto Huber, Prof.
Organizational Affiliation
University Children's Hospital, Zurich
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Children's Hospital Zurich
City
Zurich
ZIP/Postal Code
8032
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Reto Huber

12. IPD Sharing Statement

Learn more about this trial

Auditory Slow Wave Enhancement After Concussion

We'll reach out to this number within 24 hrs